Free Content Plasma N-terminal Pro-atrial Natriuretic Peptide Predicts Death after Premature Myocardial Infarction, but not as well as Radionuclide Ejection Fraction. A Ten-year Follow-up Study

Authors: Retterstol L.1; Djurovic S.2; Bohn M.3; Bakken A.3; Erikssen J.4; Berg K.1

Source: Scandinavian Cardiovascular Journal, Volume 35, Number 6, 1 December 2001 , pp. 373-378(6)

Publisher: Informa Healthcare

Buy & download fulltext article:

Free content The full text is free.

View now:
PDF

Abstract:

Objective—To assess N-terminal pro-atrial peptide (N-ANP) as a predictor of total and cardiac death in patients with previous premature myocardial infarction (MI). Design—In this prospective cohort study, we measured plasma N-ANP by ELIZA assays and ejection fraction (EF) by radionuclide ventriculography in a cohort of 247 patients (193 men and 54 women) who had had MI at a relatively young age (males: first MI at age le55; females le60). Results—After 10 years 44 patients had died, 36 from cardiac causes. After using a stepwise procedure to adjust for other prognostic factors (i.e. plasma total homocysteine (tHcy), C-reactive protein and age), the relative risk (RR) was 2.00 (95% confidence interval (CI) 1.05-3.80) (p = 0.03) for death of all causes and 2.32 (95% CI 1.19-4.55) (p = 0.01) for cardiac death when the top quartile was compared to the three lower quartiles of N-ANP. When radionuclide EF entered the Cox model, N-ANP became insignificant as a predictor of mortality. Conclusion—N-ANP was a significant predictor of total death and cardiac death in young survivors of MI, but radionuclide EF was a more independent prognostic variable.

Keywords: FOLLOW-UP STUDY; MYOCARDIAL INFARCTION; PRO-ATRIAL NATRIURETIC PEPTIDE; PROGNOSIS

Language: English

Document Type: Research article

Affiliations: 1: Department of Medical Genetics, Ullevål University Hospital, Oslo, & Institute of Medical Genetics, University of Oslo. 2: Department of Medical Genetics, Ullevål University Hospital, Oslo. 3: Department of Medical Genetics, Ullevaringl University Hospital, Oslo. l University Hospital, Oslo. "> 4: Central Hospital of Akershus, Department of Medicine, Norway.

Publication date: 2001-12-01

More about this publication?
Related content

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page